Skip to content
Drug recall · FDA · Published May 28, 2020

Glaxosmithkline Consumer Healthcare Holdings recalls Gaviscon Regular Strength Liquid Antacid Cool Mint, 12 FL OZ (355 mL), Distributed by: GSK Consumer Healthcare Warren,

Glaxosmithkline recalls Gaviscon Regular Strength Liquid Antacid Cool Mint due to missing magnesium safety warning on labels. Consumers should check product details and contact the company for guidance.

🇺🇸 FDA recall #D-1323-2020DrugGlaxosmithkline ›
Take action

Contact the company & request your remedy

Recalling firmGlaxosmithkline Consumer Healthcare Holdings184 Liberty Corner Rd · Warren, NJ 07059-6796
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

Glaxosmithkline is recalling Gaviscon Regular Strength Liquid Antacid Cool Mint because the bottle label lacks a magnesium safety warning. This could pose a risk if users are unaware of potential magnesium-related issues. Read more at govinfonow.com/recall/37091-gaviscon-regular-strength-liquid-antacid-cool-mint-recall-missing-magnesium.

Source Summary by GovInfoNow · govinfonow.com/recall/37091-gaviscon-regular-strength-liquid-antacid-cool-mint-recall-missing-magnesium · Updated October 5, 2026 · FDA enforcement record: FDA #D-1323-2020

Cite this page

“Gaviscon Regular Strength Liquid Antacid Cool Mint Recall: Missing Magnesium Safety Warning.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37091-gaviscon-regular-strength-liquid-antacid-cool-mint-recall-missing-magnesium. Based on FDA recall #D-1323-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1323-2020%22&limit=1).

Why it’s dangerous

The product label does not include a warning about magnesium safety, which could be important for individuals who need to monitor their magnesium intake. This labeling issue means users might not be aware of potential risks associated with magnesium.

Who’s affected

People who own or use the Gaviscon Regular Strength Liquid Antacid Cool Mint with the specific lot numbers listed in the recall notice. Those with magnesium sensitivity may be at higher risk.

How to tell if you have this one

Check the label for the product name 'Gaviscon Regular Strength Liquid Antacid Cool Mint', 12 fl oz (355 mL) size. Look for lot numbers 8H21C1 (exp 7/31/2020), 9B25C1 (exp 1/31/2021), 9D02C1 (exp 2/28/2021), or 9G01C1 (exp 5/31/2021).

  • Brand
    Glaxosmithkline
  • Category
    Drug
FDA recall event · 4 products

All 4 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    U.S.A. Nationwide
Recall numberProduct, codes & lotsQuantityNDC
D-1322-2020Gaviscon Regular Strength Liquid Antacid Cool Mint, 6 FL OZ (177 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-42; Lot #: 8M17C1, Exp 11/30/2020; 9E30C1, Exp 4/30/2021; 9F05C1, Exp 4/30/2021119,364 bottles0135-0094-41, 0135-0094-42, 0135-0095-41, 0135-0574-01
D-1323-2020Gaviscon Regular Strength Liquid Antacid Cool Mint, 12 FL OZ (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0094-41; Lot #: 8H21C1, Exp 7/31/2020; 9B25C1, Exp 1/31/2021; 9D02C1, Exp 2/28/2021; 9G01C1, Exp 5/31/2021151,344 bottles0135-0094-41, 0135-0094-42, 0135-0095-41, 0135-0574-01
D-1324-2020Gaviscon Extra Strength Liquid Antacid Extra Strength Cherry, 12 FL OZ. (355 mL), Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0574-41; Lot #: 0A26C1, Exp 12/31/2021; 0B10C1, Exp 1/31/2022; 8L19C1, Exp 10/31/2020; 8L27C1, Exp 10/31/2020; 9A28C1, Exp 12/31/2020; 9B18C1, Exp 1/31/2021; 9C19C1, Exp 2/28/2021; 9D09C1, Exp 3/31/2021; 9F20C1, Exp 5/31/2021; 9G24C1, Exp 6/30/2021; 9J09C1, Exp 8/31/2021; 9K29C1, Exp 9/30/2021; 9L05C1, Exp 9/30/2021629,796 bottles—
D-1325-2020Gaviscon Liquid Antacid Extra Strength, Cool Mint, 12 FL OZ (355 mL) single pack and twin pack, Distributed by: GSK Consumer Healthcare Warren, NJ 07059, NDC 0135-0095-41; Lot #: 0A21C1, Exp 12/31/2021; 0A31C1, Exp 12/31/2021; 0B05C1, Exp 12/31/2021; 8J04C1, Exp 7/31/2020; 8L05C1, Exp 9/30/200; 8L13C1 , Exp 10/31/2020; 9A14C1, Exp 12/31/2020; 9A21C1, Exp 12/31/2020; 9B04C1, Exp 12/31/2020; 9B11C1, Exp 1/31/2021; 9C04C1, Exp 1/31/2021; 9C12C1, Exp 2/28/2021; 9C25C1, Exp 2/28/2021; 9D17C1, Exp 3/312021; 9D24C1, Exp 3/312021; 9E01C1, Exp 3/31/2021; 9E10C1, Exp 3/31/2021; 9E21C1, Exp 4/30/2021; 9F11C1, Exp 5/31/2021; 9G15C1, Exp 6/30/2021; 9G30C1, Exp 6/30/2021; 9H06C1, Exp 6/30/2021; 9H12C1, Exp 7/31/2021, 9H2OC1, Exp 7/31/2021; 9H26C1, Exp 7/31/2021; 9J23C1, Exp 8/31/2021; 9J3OC1, Exp 8/31/2021; 9K08C1, Exp 8/31/2021; 9L11C1, Exp 10/31/2021; 9L18C1, Exp 10/31/2021; 9M02C1, Exp 10/31/2021; 9M09C1, Exp 11/30/2021; 9M17C1, Exp 11/30/2021; 19N1587221, Exp 7/31/2020; 19N1743754, Exp 12/31/2020; 19N1948440, Exp 6/30/2021; 19N1958219, Exp 6/30/2021; 20N2019997, Exp 7/31/2021; 20N2026258, Exp 8/31/2021; 20N2057778, Exp 8/31/20211,631,700 bottles & 27,300 Twin-Pack botles0135-0094-41, 0135-0094-42, 0135-0095-41, 0135-0574-01
Based on the official FDA remedy

What to do — step by step

  1. Check Product Label

    Look for the lot numbers 8H21C1, 9B25C1, 9D02C1, or 9G01C1 on the bottle to confirm if the product is recalled.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The product may be safe for most users, but the missing magnesium safety warning could be important for individuals with magnesium sensitivity. Check the label for the specific lot numbers listed in the recall.

What should I do if I have the recalled product?

The recall does not specify a remedy, so contact Glaxosmithkline Consumer Healthcare for guidance on next steps.

How can I tell if my product is recalled?

Check the label for the product name 'Gaviscon Regular Strength Liquid Antacid Cool Mint', 12 fl oz (355 mL), and lot numbers 8H21C1, 9B25C1, 9D02C1, or 9G01C1.

Take action

Contact Glaxosmithkline

We’ve drafted a message you can send Glaxosmithkline to request your refund or repair — edit it as you like.

Subject: Recall D-1323-2020 — Glaxosmithkline Glaxosmithkline

Hello,

I own a Glaxosmithkline that is covered by recall D-1323-2020 from Glaxosmithkline.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1323-2020 (May 28, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1323-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA